Novartis to sell its Roche stake for $20.7 billion - NewsBreak

Novartis (NYSE: NVS) agreed to sell its nearly one-third stake in Roche (Swiss: ROG) back to the company for around $20.7 billion. Why it matters: This is the final chapter of a story that began in 2001, when Novartis launched an unsuccessful effort to buy its crosstown rival. It will help...